Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             38 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients Honing, J.

25 3 p. 638-643
artikel
2 An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients Regierer, A.C.

25 3 p. 633-638
artikel
3 A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG † Smorenburg, C.H.

25 3 p. 599-605
artikel
4 Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials Gandini, S.

25 3 p. 618-623
artikel
5 Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer Arnedos, M.

25 3 p. 605-610
artikel
6 Breaking bad news–what patients want and what they get: evaluating the SPIKES protocol in Germany Seifart, C.

25 3 p. 707-711
artikel
7 Cancer evolution: the final frontier of precision medicine? Swanton, Charles

25 3 p. 549-551
artikel
8 Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study Houvenaeghel, G.

25 3 p. 623-628
artikel
9 Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part) Vermorken, J.B.

25 3 p. 682-688
artikel
10 Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer Leibowitz-Amit, R.

25 3 p. 657-662
artikel
11 Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer—a dose–response meta-analysis Discacciati, A.

25 3 p. 584-591
artikel
12 Differential influence of vemurafenib and dabrafenib on patients’ lymphocytes despite similar clinical efficacy in melanoma Schilling, B.

25 3 p. 747-753
artikel
13 Editorial board
25 3 p. ii-iii
artikel
14 Effect of marital status on treatment and survival of extremity soft tissue sarcoma Alamanda, V.K.

25 3 p. 725-729
artikel
15 Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review Puts, M.T.E.

25 3 p. 564-577
artikel
16 Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer
25 3 p. 757
artikel
17 Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study Schadendorf, D.

25 3 p. 700-706
artikel
18 Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors Dienstmann, R.

25 3 p. 552-563
artikel
19 Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial Leyvraz, S.

25 3 p. 742-746
artikel
20 Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072 Kasper, B.

25 3 p. 719-724
artikel
21 Metastatic pattern in colorectal cancer is strongly influenced by histological subtype Hugen, N.

25 3 p. 651-657
artikel
22 On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points? † Hamaker, M.E.

25 3 p. 675-681
artikel
23 Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups
25 3 p. 756
artikel
24 Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer Baselga, J.

25 3 p. 592-598
artikel
25 Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III–IVB head and neck squamous cell carcinoma (HNSCC) Fury, M.G.

25 3 p. 689-694
artikel
26 Plasma testosterone in the general population, cancer prognosis and cancer risk: a prospective cohort study Ørsted, D.D

25 3 p. 712-718
artikel
27 Prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer—a problem still to be solved Schmidt, M.

25 3 p. 754
artikel
28 Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study Dieci, M.V.

25 3 p. 611-618
artikel
29 Reply to: Prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer Goldhirsch, A.

25 3 p. 755
artikel
30 Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group Toulmonde, M.

25 3 p. 735-742
artikel
31 Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group Toulmonde, M.

25 3 p. 730-734
artikel
32 Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm—a position paper from the Italian and the French Sarcoma Group Gronchi, A.

25 3 p. 578-583
artikel
33 Table of Contents
25 3 p. iv-vi
artikel
34 The impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjects † Wöckel, A.

25 3 p. 628-632
artikel
35 The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer Park, J.H.

25 3 p. 644-651
artikel
36 The role of body mass index in survival outcome for lymphoma patients: US intergroup experience Hong, F.

25 3 p. 669-674
artikel
37 Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies Voss, M.H.

25 3 p. 663-668
artikel
38 Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis Bossi, P.

25 3 p. 694-699
artikel
                             38 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland